𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Levodopa/carbidopa/entacapone-induced acute Pisa syndrome in a Parkinson’s disease patient

✍ Scribed by Paolo Solla; Antonino Cannas; Socrate Congia; Gianluca Floris; Rosa Aste; Paolo Tacconi; Maria Giovanna Marrosu

Book ID
119302784
Publisher
Elsevier Science
Year
2008
Tongue
English
Weight
405 KB
Volume
275
Category
Article
ISSN
0022-510X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Double-blind trial of levodopa/carbidopa
Double-blind trial of levodopa/carbidopa/entacapone versus levodopa/carbidopa in early Parkinson's disease
✍ Robert A. Hauser; Michel Panisset; Giovanni Abbruzzese; Linda Mancione; Nalina D 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 443 KB

## Abstract We performed a 39‐week, randomized, double‐blind, multicenter study to compare the efficacy, safety, and tolerability of levodopa/carbidopa/entacapone (LCE, Stalevo) with levodopa/carbidopa (LC, Sinemet IR) in patients with early Parkinson's disease (PD). Four hundred twenty‐three patie

Quality of life in early Parkinson's dis
Quality of life in early Parkinson's disease treated with levodopa/carbidopa/entacapone
✍ Victor S.C. Fung; Lilie Herawati; Ying Wan 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 172 KB

## Abstract We aimed to investigate whether treatment with levodopa/carbidopa/entacapone when compared with levodopa/carbidopa improves quality of life in Parkinson's disease (PD) patients with no or minimal, nondisabling motor fluctuations. This is a multicenter, randomized, double‐blind study. On